Femasys Inc. (FEMY)
USD 1.12
(-2.61%)
USD 1.12
(-2.61%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -14.24 Million USD | -25.04% |
| 2022 | -11.39 Million USD | -51.16% |
| 2021 | -7.53 Million USD | -9.01% |
| 2020 | -6.91 Million USD | 38.65% |
| 2019 | -11.27 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -4.68 Million USD | -30.14% |
| 2024 Q1 | -3.59 Million USD | 18.39% |
| 2023 Q2 | -2.89 Million USD | -1.44% |
| 2023 FY | -14.24 Million USD | -25.04% |
| 2023 Q4 | -4.41 Million USD | -10.35% |
| 2023 Q3 | -3.99 Million USD | -38.13% |
| 2023 Q1 | -2.85 Million USD | 1.44% |
| 2022 Q2 | -2.6 Million USD | 9.54% |
| 2022 Q1 | -2.88 Million USD | -21.92% |
| 2022 Q4 | -2.89 Million USD | 0.49% |
| 2022 FY | -11.39 Million USD | -51.16% |
| 2022 Q3 | -2.9 Million USD | -11.51% |
| 2021 FY | -7.53 Million USD | -9.01% |
| 2021 Q2 | -1.08 Million USD | 40.82% |
| 2021 Q4 | -2.36 Million USD | -4.65% |
| 2021 Q3 | -2.25 Million USD | -108.64% |
| 2021 Q1 | -1.83 Million USD | -10.29% |
| 2020 FY | -6.91 Million USD | 38.65% |
| 2020 Q1 | -2.2 Million USD | 0.0% |
| 2020 Q4 | -1.65 Million USD | -5.82% |
| 2020 Q3 | -1.56 Million USD | -5.58% |
| 2020 Q2 | -1.48 Million USD | 32.53% |
| 2019 FY | -11.27 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 77.501% |
| AngioDynamics, Inc. | -184.34 Million USD | 92.272% |
| AtriCure, Inc. | -30.43 Million USD | 53.193% |
| Avinger, Inc. | -18.32 Million USD | 22.232% |
| Azenta, Inc. | -14.25 Million USD | 0.069% |
| BioLife Solutions, Inc. | -66.42 Million USD | 78.552% |
| The Cooper Companies, Inc. | 294.2 Million USD | 104.843% |
| Daxor Corporation | 280.64 Thousand USD | 5176.655% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | 6.257% |
| GlucoTrack, Inc. | -7.09 Million USD | -100.749% |
| Harvard Bioscience, Inc. | -3.41 Million USD | -317.193% |
| Hologic, Inc. | 789.5 Million USD | 101.805% |
| ICU Medical, Inc. | -29.65 Million USD | 51.957% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 100.792% |
| KORU Medical Systems, Inc. | -13.74 Million USD | -3.683% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 147.325% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -113.811% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -113.811% |
| Masimo Corporation | 81.5 Million USD | 117.481% |
| Microbot Medical Inc. | -10.74 Million USD | -32.655% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | 222.552% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 115.091% |
| Nephros, Inc. | -1.57 Million USD | -804.579% |
| NovoCure Limited | -207.04 Million USD | 93.119% |
| NEXGEL, Inc. | -3.15 Million USD | -351.287% |
| NEXGEL, Inc. | -3.15 Million USD | -351.287% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 84.975% |
| OraSure Technologies, Inc. | 53.65 Million USD | 126.553% |
| Pro-Dex, Inc. | 2.12 Million USD | 769.822% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 66.247% |
| Predictive Oncology Inc. | -13.98 Million USD | -1.882% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | -382.728% |
| QuidelOrtho Corporation | -10.1 Million USD | -41.061% |
| Repligen Corporation | 41.57 Million USD | 134.267% |
| Sanara MedTech Inc. | -4.3 Million USD | -231.082% |
| STAAR Surgical Company | 21.34 Million USD | 166.741% |
| Sharps Technology, Inc. | -9.84 Million USD | -44.764% |
| Utah Medical Products, Inc. | 16.63 Million USD | 185.645% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 89.207% |
| Jin Medical International Ltd. | 2.87 Million USD | 594.996% |